Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model. Long, BJ, Jelovac D, Handratta V, Thiantanawat A, MacPherson N, Ragaz J, Goloubeva OG, Brodie AM J Natl Cancer Inst 2004; 96: 456-65.

17 Mar 2004
0

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.
Long, BJ, Jelovac D, Handratta V, Thiantanawat A, MacPherson N, Ragaz J, Goloubeva OG, Brodie AM
J Natl Cancer Inst 2004; 96: 456-65.

Tags

Share this

Related Posts

One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission. Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, Mongkolsuk S, Pitchforth E, Reyher KK, Sakcamduang W, Satayavivad J, Singer AC, Sringernyuang L, Thamlikitkul V, Vass L; OH-DART Study Group, Avison MB, Turner KME. One Health. 2021 Jan 26;12:100220. doi: 10.1016/j.onehlt.2021.100220. eCollection 2021 Jun. PMID: 33644290
Sureram, S.; Wiyakrutta, S.; Ngamrojanavanich, N.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Depsidones, Aromatase Inhibitors and Radical Scavenging Agents from the Marine-Derived Fungus Aspergillus unguis CRI282-03. Planta Med. 2012 ,78(6), 582-588

Recent Posts